Glenmark gets tentative nod from USFDA for epilepsy drug
Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its generic version of Vimpat Oral Solution, used in treatment of epilepsy.
Mar 18, 2016, 12:05 PM IST